{
    "Trade/Device Name(s)": [
        "U-RIGHT TD-4116 Blood Glucose Monitoring System",
        "U-RIGHT TD-4116 Pro Blood Glucose Monitoring System"
    ],
    "Submitter Information": "TaiDoc Technology Corporation",
    "510(k) Number": "K151100",
    "Predicate Device Reference 510(k) Number(s)": [
        "K090188"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "CGA"
    ],
    "Summary Letter Date": "August 27, 2015",
    "Summary Letter Received Date": "August 31, 2015",
    "Submission Date": "September 28, 2015",
    "Regulation Number(s)": [
        "21CFR862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "U-RIGHT TD-4116 Blood Glucose Meter",
        "U-RIGHT TD-4116 Pro Blood Glucose Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric biosensor",
        "Glucose oxidase reaction"
    ],
    "Methodologies": [
        "Electrical current measurement"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for U-RIGHT TD-4116 and TD-4116 Pro Blood Glucose Monitoring Systems for quantitative glucose measurement in capillary whole blood",
    "Indications for Use Summary": "Intended for quantitative measurement of glucose in fresh capillary whole blood from finger and alternative sites; for self-testing by people with diabetes (TD-4116) and for professional use in clinical settings (TD-4116 Pro) as an aid to monitor diabetes control, not for diagnosis, screening, or use on neonates",
    "fda_folder": "Clinical Chemistry"
}